Therini Bio
Sacramento, CA · Biotechnology · 10 employees
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UC
Funding history
- Funding Round — $74.9M — Sep 2025
- Series series a — $39.0M — May 2025
- Funding Round — $74.9M — Apr 2023
- Funding Round — $9.4M — May 2020
- Series seed — $2.4M — May 2019
Recent signals
- Sep 08, 2025: Raised $74.9M
- May 14, 2025: Raised $39.0M in Series series a
- Apr 14, 2023: Raised $74.9M
- May 22, 2020: Raised $9.4M
- May 17, 2019: Raised $2.4M in Series seed
See plans & pricing → Track Therini Bio’s funding, hiring, and signals — with verified contacts — on Fundz.